The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Boston Scientific to Announce First-Quarter 2012 Financial Results on April 19

Tuesday, April 10, 2012

Boston Scientific to Announce First-Quarter 2012 Financial Results on April 1914:28 EDT Tuesday, April 10, 2012NATICK, Mass., April 10, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces it will webcast its first-quarter 2012 financial results conference call on Thursday, April 19, at 8:00 a.m. Eastern Time.The call will be hosted by Hank Kucheman, chief executive officer, and Jeff Capello, executive vice president and chief financial officer.A live webcast of the conference call will be available via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.The webcast is also being distributed over Thomson Reuters Investor Distribution Network via two locations:, which is accessible to the public, and, a password-protected event management site.An archived replay of the webcast will be accessible at approximately one hour following the completion of the conference call and available for approximately one year.The Company will issue a press release announcing first-quarter 2012 financial results prior to the conference call on Thursday, April 19.About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit:   CONTACT:    Steven Campanini508-652-5740 (office)Media RelationsBoston Scientific Corporation steven.campanini@bsci.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporation Investor_Relations@bsci.comSOURCE Boston Scientific Corporation